Tumor Cell JAGGED-1 Promotes Lymph Node Metastasis and Predicts Recurrence in Lymph Node Positive Breast Cancer Patients
RNA-seq (gene expression) · human · 27 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Topic
- Breast cancerThis series is part of our curated briefing on it.
- Samples
- 27 samples: 8 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Tumor cell Jagged-1 promotes regional lymphatic metastasis and predicts recurrence in node-positive breast cancerBreast cancer research : BCR · 2026
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE253036_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1063681 and SRA study SRP482957. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 3 samples read as cases, 3 as controls.
How we read this: 8 replicated groups read from 27 sample titles; they account for 23 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8010890 MDA-MB-231-D3H2LN cells expressing JAG1 rep1 MDA-MB-231-D3H2LN cells…
- GSM8010891 MDA-MB-231-D3H2LN cells expressing JAG1 rep2 MDA-MB-231-D3H2LN cells…
- GSM8010892 MDA-MB-231-D3H2LN cells expressing JAG1 rep3 MDA-MB-231-D3H2LN cells…
- GSM8010893 MDA-MB-231-D3H2LN cells with CRISPR/Cas9 JAG1 deletion - clone 1 (E) rep1 MDA-MB-231-D3H2LN cells…
- GSM8010894 MDA-MB-231-D3H2LN cells with CRISPR/Cas9 JAG1 deletion - clone 1 (E) rep2
- GSM8010895 MDA-MB-231-D3H2LN cells with CRISPR/Cas9 JAG1 deletion - clone 1 (E) rep3 MDA-MB-231-D3H2LN cells…
- GSM8010896 MDA-MB-231-D3H2LN cells with CRISPR/Cas9 JAG1 deletion - clone 2 (F) rep1
- GSM8010897 MDA-MB-231-D3H2LN cells with CRISPR/Cas9 JAG1 deletion - clone 2 (F) rep2
- GSM8010898 MDA-MB-231-D3H2LN cells with CRISPR/Cas9 JAG1 deletion - clone2 (F) rep3
- GSM8010905 MDA-MB-231-D3H2LN with JAG1 KO 1 MDA-MB-231-D3H2LN with …
- GSM8010906 MDA-MB-231-D3H2LN with JAG1 KO 2 MDA-MB-231-D3H2LN with …
- GSM8010907 MDA-MB-231-D3H2LN with JAG1 KO 3 MDA-MB-231-D3H2LN with …
- GSM8010908 MDA-MB-231-D3H2LN with JAG1 KO + JAG1 OE (rescue) 1 MDA-MB-231-D3H2LN with …
- GSM8010909 MDA-MB-231-D3H2LN with JAG1 KO + JAG1 OE (rescue) 2 MDA-MB-231-D3H2LN with …
- GSM8010910 MDA-MB-231-D3H2LN with JAG1 KO + JAG1 OE (rescue) 3 MDA-MB-231-D3H2LN with …
- GSM8010911 HdLEC Control 1 HdLEC Control
- GSM8010912 HdLEC Control 2 HdLEC Control
- GSM8010913 HdLEC Control 3 HdLEC Control
- GSM8010914 HdLEC JAG1 stimulated 1 HdLEC JAG1 stimulated
- GSM8010915 HdLEC JAG1 stimulated 2 HdLEC JAG1 stimulated
- GSM8010916 HdLEC JAG1 stimulated 3 HdLEC JAG1 stimulated
- GSM8012707 MDA-MB-231 cells rep 1 MDA-MB-231 cells
- GSM8012708 MDA-MB-231 cells rep 2 MDA-MB-231 cells
- GSM8012709 MDA-MB-231 cells rep 3 MDA-MB-231 cells
- GSM8012710 MDA-MB-231-D3H2LN (MDA231LN) rep 1 MDA-MB-231-D3H2LN (MDA2…
- GSM8012711 MDA-MB-231-D3H2LN (MDA231LN) rep 2 MDA-MB-231-D3H2LN (MDA2…
- GSM8012712 MDA-MB-231-D3H2LN (MDA231LN) rep 3 MDA-MB-231-D3H2LN (MDA2…
- GSE104193 Hypoxia-mediated translational activation of ITGB3 in breast cancer cells enhances TGF-β signalling and malignant features in vitro and in vivo 32 samples same disease briefing · shares breast
- GSE104675 Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 6 samples same disease briefing · shares breast
- GSE10886 A Supervised Risk Predictor of Breast Cancer Based on Biological Subtypes 226 samples same disease briefing · shares breast
- GSE11121 The humoral immune system has a key prognostic impact in node-negative breast cancer 200 samples same disease briefing · shares breast
- GSE10885 An integromic analysis reveals that metaplastic carcinomas are distinct from basal-like tumors. 244 samples same disease briefing
- GSE273829 GABA promotes resistance to immunotherapy of patients with TLS-positive tumors [RNA-seq] 92 samples shares promotes, positive
- GSE289930 Proteogenomic Characterization of Primary Oral Cancer Unveils Extracellular Matrix Remodeling and Immunosuppressive Microenvironment Linked to Lymph Node Metastasis [RNA-seq] 33 samples shares metastasis, lymph
- GSE277742 Immune Landscape of Intrathoracic Lymph Nodes with Metastasis in Primary Lung Malignancy using EBUS-TBNA samples 22 samples shares metastasis, lymph
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.